Therapeutic Asset Ratings
3,187 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ML261
Prostate Neuroendocrine Neoplasm
Moonlight Bio, Inc
P1
CC
(43)
ML261
Small Cell Lung Carcinoma
Moonlight Bio, Inc
P1
CC
(43)
Mm-Specific Universal Car T Cells
Plasma Cell Myeloma
Shenzhen Geno-Immune Medical Institute
P1
CC
(43)
mov19-bbz car t cells
Non-Small Cell Lung Carcinoma
University of Pennsylvania
P1
CC
(43)
mt027 car-t cells
Primary Peritoneal Carcinoma
Zhejiang University
P1
CC
(43)
Neldaleucel
Non-Hodgkin Lymphoma
Marker Therapeutics, Inc.
P1
CC
(43)
Newly Matched Donor-Derived Fl-33 Car T Therapy
Acute Myeloid Leukemia
Beijing GoBroad Hospital
P1
CC
(43)
NKG2D CAR-NK
Metastatic Malignant Neoplasm
Zhejiang University
P1
CC
(43)
nkg2d-car-nk92 cells
Refractory Malignant Neoplasm
Henan Medical University
P1
CC
(43)
nkg2d car t-cells
Metastatic Malignant Neoplasm
Zhejiang University
P1
CC
(43)
nkx019
Aggressive B-Cell Non-Hodgkin Lymphoma
Nkarta, Inc.
P1
CC
(43)
nkx019
Anaplastic Large Cell Lymphoma
Nkarta, Inc.
P1
CC
(43)
nkx101 - car nk cell therapy
Acute Myeloid Leukemia
Nkarta, Inc.
P1
CC
(43)
nw-101c
Metastatic Malignant Neoplasm
Neowise Biotechnology
P1
CC
(43)
nw-301vt
Neoplasm
Zhejiang University
P1
CC
(43)
Ny-Eso-1 Tcr Redirected Autologous T Cell Product
Metastatic Melanoma
Centre Hospitalier Universitaire Vaudois
P1
CC
(43)
Obecabtagene Autoleucel Chimeric Antigen Receptor
Chronic Progressive Multiple Sclerosis
Autolus Limited
P1
CC
(43)
Obx-115
Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
Orca-Q
Secondary Progressive Multiple Sclerosis
Stanford University
P1
CC
(43)
Orca-Q
Primary Progressive Multiple Sclerosis
Stanford University
P1
CC
(43)
Oricar-017
Hematologic Disorder
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Hemorrhagic Disease
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Vascular Hemostatic Disease
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Immune System Disorder
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Oricar-017
Immunoproliferative Disorder
OriCell Therapeutics Co., Ltd.
P1
CC
(43)
Showing 1476 to 1500 of 3,187 assets
Previous
Page 60 of 128
Next